Transcriptomic profiling and analysis of the protein–RNA interactions of SARS-CoV-2-infected human cell lines identified HSP90 as a target for COVID-19 therapy [134,172], which gives credence to the theoretical recognition code and the methodological pipeline used here to identify the genes. The gene discussed is HSP90AA1; the disease is COVID-19.